About Nirvana Sciences
Nirvana Sciences is a company based in Durham (United States) founded in 2013.. Nirvana Sciences has raised $3.5 million across 7 funding rounds from investors including HHS and ThreeD Capital. Nirvana Sciences offers products and services including Synthetic Bacteriochlorins, Synthetic Chlorins, and Polystyrene Beads. Nirvana Sciences operates in a competitive market with competitors including NuProbe, Nanosphere, 3Helix, ATDBio and OliLux, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nirvana Sciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.5 M (USD)
in 7 rounds
-
Latest Funding Round
$867 K (USD), Series A
May 26, 2021
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nirvana Sciences
Nirvana Sciences offers a comprehensive portfolio of products and services, including Synthetic Bacteriochlorins, Synthetic Chlorins, and Polystyrene Beads. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Dyes with narrow emissions for life science multiplexing applications
Dyes offering enhanced properties for biomedical research needs
Beads with red and near-infrared emissions for scientific uses
Unlock access to complete
Unlock access to complete
Advisor Team
4 people
Member Team
2 people
Finance and Accounting
2 people
Leadership Team
1 people
Chairman Team
1 people
Unlock access to complete
Funding Insights of Nirvana Sciences
Nirvana Sciences has successfully raised a total of $3.5M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $867 thousand completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $867,000
-
First Round
First Round
(15 Jun 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2021 | Amount | Series A - Nirvana Sciences | Valuation |
investors |
|
| Feb, 2021 | Amount | Series A - Nirvana Sciences | Valuation | ThreeD Capital |
|
| Sep, 2018 | Amount | Grant - Nirvana Sciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nirvana Sciences
Nirvana Sciences has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and ThreeD Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nirvana Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nirvana Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nirvana Sciences Comparisons
Competitors of Nirvana Sciences
Nirvana Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuProbe, Nanosphere, 3Helix, ATDBio and OliLux, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sensitive multiplex platforms for QPCR are developed using toehold probes.
|
|
| domain | founded_year | HQ Location |
Diagnostic tests for personalized medicine targeting infections are provided.
|
|
| domain | founded_year | HQ Location |
Reagents for binding denatured collagen are developed and offered.
|
|
| domain | founded_year | HQ Location |
Developer of oligonucleotides
|
|
| domain | founded_year | HQ Location |
Tuberculosis detection dyes are provided by OliLux.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Nirvana Sciences
When was Nirvana Sciences founded?
Nirvana Sciences was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Nirvana Sciences located?
Nirvana Sciences is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Is Nirvana Sciences a funded company?
Nirvana Sciences is a funded company, having raised a total of $3.5M across 7 funding rounds to date. The company's 1st funding round was a Grant of $1.94M, raised on Jun 15, 2014.
What does Nirvana Sciences do?
Nirvana Sciences was established in 2013 in Durham, United States, within the medical diagnostics sector. Fluorescent dyes are produced and supplied for imaging systems and tests. These dyes feature ultra-narrow emissions to simplify detection processes and support multiplexing in research applications. Utilization occurs in areas such as flow cytometry, imaging cytometry, photoacoustic imaging, and various molecular diagnostics.
Who are the top competitors of Nirvana Sciences?
Nirvana Sciences's top competitors include NuProbe, Nanosphere and ATDBio.
What products or services does Nirvana Sciences offer?
Nirvana Sciences offers Synthetic Bacteriochlorins, Synthetic Chlorins, and Polystyrene Beads.
Who are Nirvana Sciences's investors?
Nirvana Sciences has 2 investors. Key investors include HHS, and ThreeD Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.